Results 21 to 30 of about 11,237 (163)

The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients

open access: yesKaohsiung Journal of Medical Sciences, 2012
This study investigated the differences in clinical and laboratory features as well as treatment response in 70 outpatients with macroprolactinemia and monomeric hyperprolactinemia treated with dopamine agonists.
Chih-Chin Lu, Ching-Jung Hsieh
doaj   +1 more source

Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines? [PDF]

open access: yesРМЖ. Мать и дитя, 2020
Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines? A.A. Olina D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproduction, St.
A.A. Olina
doaj  

Hyperprolactinemia and Hypopituitarism in Acromegaly and Effect of Pituitary Surgery: Long-Term Follow-up on 529 Patients

open access: yesFrontiers in Endocrinology, 2022
PurposeStudies on hyperprolactinemia and hypopituitarism in acromegaly are limited. We aimed to analyze the preoperative status, postoperative alterations, and correlated factors of hyperprolactinemia and hypopituitarism in acromegaly patients ...
Xiaopeng Guo   +57 more
doaj   +1 more source

Epigenetics in etiopathology of hyperprolactinemia [PDF]

open access: yesExploration of Endocrine and Metabolic Diseases
Aim: Epigenetic alterations have been reported in patients with pituitary tumors and those on antipsychotic drugs, which are also responsible for hyperprolactinemia. This suggests a possible role of epigenetics in the etiopathology of hyperprolactinemia.
Amanpreet Kaur Kalsi   +3 more
doaj   +1 more source

Depression, anxiety, sexual function and quality of life in women with hyperprolactinemia [PDF]

open access: yesRevista Brasileira de Ginecologia e Obstetrícia
Objective: To evaluate anxiety, depression, sexual function and quality of life in women with hyperprolactinemia. Methods: Cross-sectional study with 80 women divided into two groups: 30 women with hyperprolactinemia (Study Group) followed and treated ...
Renan Massao Nakamura   +7 more
doaj   +1 more source

Etiopathogenetic features of hyperprolactinemia in childhood

open access: yesZdorovʹe Rebenka, 2021
In recent years, the problem of hyperprolactinemia in children remains relevant because it is one of the most common pathologies of the hypothalamic-pituitary system, causing impaired fertility and reproductive function in adulthood.
O.E. Abaturov   +2 more
doaj   +1 more source

IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome

open access: yesAdvanced Science, EarlyView.
Impaired endometrial receptivity contributes to the poor pregnancy outcomes in women with PCOS. The authors found that decreased endometrial IL‐22 levels and disrupted STAT3‐IGFBP5 signaling pathway contributed to impaired endometrial receptivity. Supplementation with IL‐22 or IGFBP5 exerts a protective effect on implantation failure in PCOS‐like mice,
Baoying Liao   +13 more
wiley   +1 more source

Treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)

open access: yesArchives of Endocrinology and Metabolism
Dopamine agonists are the first line of treatment for patients with symptomatic hyperprolactinemia due to prolactinomas and in those with idiopathic hyperprolactinemia. Treatment with these agents is effective in 80%-90% of the cases.
Cristina Laguna Benetti-Pinto   +9 more
doaj   +1 more source

Kisspeptin as a test of hypothalamic dysfunction in pubertal and reproductive disorders

open access: yesAndrology, EarlyView.
Abstract The hypothalamic–pituitary–gonadal axis is regulated by the gonadotropin‐releasing hormone pulse generator in the hypothalamus. This is comprised of neurons that secrete kisspeptin in a pulsatile manner to stimulate the release of GnRH, and, in turn, downstream gonadotropins from the pituitary gland, and subsequently sex steroids and ...
Aureliane C. S. Pierret   +5 more
wiley   +1 more source

Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)

open access: yesArchives of Endocrinology and Metabolism
Hyperprolactinemia is a frequent cause of menstrual irregularity, galactorrhea, hypogonadism, and infertility. The most common etiologies of hyperprolactinemia can be classified as physiological, pharmacological, and pathological.
Andrea Glezer   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy